|
Name |
(R,Z)-2-Methyl-6-(4-methylcyclohexa-1,4-dien-1-yl)hept-2-en-1-ol
|
Molecular Formula | C15H24O | |
IUPAC Name* |
(Z,6R)-2-methyl-6-(4-methylcyclohexa-1,4-dien-1-yl)hept-2-en-1-ol
|
|
SMILES |
CC1=CCC(=CC1)[C@H](C)CC/C=C(/C)\CO
|
|
InChI |
InChI=1S/C15H24O/c1-12-7-9-15(10-8-12)14(3)6-4-5-13(2)11-16/h5,7,10,14,16H,4,6,8-9,11H2,1-3H3/b13-5-/t14-/m1/s1
|
|
InChIKey |
ZHWZEHFYKZGQFR-MECSIWFOSA-N
|
|
Synonyms |
(Z)-beta-Curcumene-12-ol; (Z)-.beta.-Curcumen-12-ol; .beta.-(Z)-Curcumen-12-ol; (R,Z)-2-Methyl-6-(4-methylcyclohexa-1,4-dien-1-yl)hept-2-en-1-ol; 2-Hepten-1-ol, 2-methyl-6-(4-methyl-1,4-cyclohexadien-1-yl)-, (2Z,6R)-
|
|
CAS | NA | |
PubChem CID | 91710638 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 220.35 | ALogp: | 3.5 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.669 |
Caco-2 Permeability: | -4.486 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0.084 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.999 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.591 | Plasma Protein Binding (PPB): | 95.51% |
Volume Distribution (VD): | 3.376 | Fu: | 3.31% |
CYP1A2-inhibitor: | 0.665 | CYP1A2-substrate: | 0.235 |
CYP2C19-inhibitor: | 0.142 | CYP2C19-substrate: | 0.445 |
CYP2C9-inhibitor: | 0.077 | CYP2C9-substrate: | 0.53 |
CYP2D6-inhibitor: | 0.24 | CYP2D6-substrate: | 0.72 |
CYP3A4-inhibitor: | 0.272 | CYP3A4-substrate: | 0.242 |
Clearance (CL): | 9.647 | Half-life (T1/2): | 0.888 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.133 |
Drug-inuced Liver Injury (DILI): | 0.187 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.014 | Maximum Recommended Daily Dose: | 0.643 |
Skin Sensitization: | 0.914 | Carcinogencity: | 0.877 |
Eye Corrosion: | 0.059 | Eye Irritation: | 0.955 |
Respiratory Toxicity: | 0.087 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000197 | 0.479 | D0M1PQ | 0.250 | ||||
ENC002218 | 0.441 | D03VFL | 0.196 | ||||
ENC002339 | 0.375 | D0O1UZ | 0.189 | ||||
ENC005805 | 0.361 | D05XQE | 0.182 | ||||
ENC001868 | 0.361 | D0U5CE | 0.180 | ||||
ENC001869 | 0.361 | D03LGG | 0.180 | ||||
ENC000804 | 0.338 | D06GIP | 0.177 | ||||
ENC000796 | 0.328 | D0S7WX | 0.174 | ||||
ENC001738 | 0.313 | D00FSV | 0.174 | ||||
ENC002844 | 0.308 | D06LYG | 0.173 |